-
Medical Physics Nov 1995
Review
Topics: France; History, 19th Century; History, 20th Century; Nobel Prize; Physics; Radioactivity; Research
PubMed: 8587540
DOI: 10.1118/1.597442 -
Nature Apr 2020
PubMed: 32235936
DOI: 10.1038/d41586-020-00909-5 -
Physica Medica : PM : An International... Jul 2021This year it is 125 years since Henri Becquerel accidentally discovered radioactivity. It has been argued that this was the result after Becquerel's long, systematic...
This year it is 125 years since Henri Becquerel accidentally discovered radioactivity. It has been argued that this was the result after Becquerel's long, systematic research into the phenomenon of luminescence. Becquerel's discovery, together with Marie and Pierre Curie's discovery of radium, became the breakthrough for the 20th century research in medical radiation physics and the use of radioactivity in medicine. In this paper, we draw attention to Becquerel's discovery and the impact it had on medicine and society.
Topics: History, 19th Century; History, 20th Century; Luminescence; Nuclear Medicine; Radioactivity; Radium
PubMed: 33962859
DOI: 10.1016/j.ejmp.2021.03.032 -
Environmental Advances Jul 2022
PubMed: 35782591
DOI: 10.1016/j.envadv.2022.100216 -
The Dental Register Jul 1862
PubMed: 33696606
DOI: No ID Found -
Radiological Physics and Technology Jan 2015
Topics: France; History, 19th Century; History, 20th Century; Humans; Radioactivity; Radiography
PubMed: 25318898
DOI: 10.1007/s12194-014-0292-z -
European Journal of Medicinal Chemistry Oct 2017Alzheimer's Disease (AD) is a neurodegenerative brain disorder in which many biological dysfunctions are involved. Among them, two main types of lesions were discovered... (Review)
Review
Alzheimer's Disease (AD) is a neurodegenerative brain disorder in which many biological dysfunctions are involved. Among them, two main types of lesions were discovered and widely studied: the amyloid plaques and the neurofibrillary tangles (NFTs). These two lesions are caused by the dysfunction and the accumulation of two proteins which are, respectively, the beta-amyloid peptide and the tau protein. The process that leads these two proteins to aggregate is complex and is the subject of current studies. After a brief description of the aggregation mechanisms, we will provide an overview of new therapeutic agents targeting the different dysfunctions and toxic species found during aggregation.
Topics: Alzheimer Disease; Animals; Humans; Neuroprotective Agents; Protein Aggregates; tau Proteins
PubMed: 28800454
DOI: 10.1016/j.ejmech.2017.07.070 -
European Journal of Nuclear Medicine May 1996
Topics: France; Germany; History, 19th Century; History, 20th Century; Humans; London; Nuclear Medicine; Radioactivity; United States
PubMed: 8698049
DOI: 10.1007/BF00833379 -
The Journal of Molecular Diagnostics :... Mar 2018Authors' Reply to the Letter to the Editor by Y. Lynn Wang (MYD88 mutations and sensitivity to ibrutinib therapy).
Authors' Reply to the Letter to the Editor by Y. Lynn Wang (MYD88 mutations and sensitivity to ibrutinib therapy).
Topics: Adenine; Mutation; Myeloid Differentiation Factor 88; Piperidines; Pyrazoles; Pyrimidines
PubMed: 29482771
DOI: 10.1016/j.jmoldx.2017.12.001 -
Journal of Nuclear Medicine : Official... Jul 1976
Topics: France; History, 19th Century; History, 20th Century; Nuclear Physics; Radioactivity
PubMed: 775027
DOI: No ID Found